A Clinical Study to Map the HLA Genomic Region in the Greek Population
Recruiting
Observational Study
Healthy
Respiratory Disease
Chronic Renal Failure
Cardiovascular Diseases
Metabolic Disease
Psychiatric Disorder
Neurologic Disorder
Gastrointestinal Diseases
Haematologic Disease
Rheumatologic Disease
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 12,000 (estimated)
- Sponsor
- Athens LifeTech Park · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The aim of GENESIS clinical study is to map the HLA genomic region in the Greek population and evaluate possible correlations with selected underlying diseases.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
The study will include adult subjects (age ≥ 18) that:
* possess a Greek social security number and are visiting hospitals/clinics, and/or other private laboratory institutions (incl. clinics and health care groups) as part of standard clinical practice in Greece,
* are willing…
Contacts